Loss of Competitiveness Due to Intensifying Competition and Technological Innovation in the Pharmaceutical Industry

Risk that intensified competition from pharmaceutical companies and research institutions in Japan and overseas, together with rapid technological innovation, will reduce the competitiveness of existing products and research and development, affecting financial position and operating results.